Amneal Pharmaceuticals Inc (AMRX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | N/A | -0.961 | -9.027 | 2.374 | 0.267 | -3.359 | -2.31 |
Return on Equity (%) | N/A | -4.668 | -58.226 | 26.328 | 2.985 | -47.186 | -82.35 |
Return on Invested Capital (%) | N/A | 6.636 | -14.377 | 14.005 | 10.347 | 2.817 | 15.41 |
Operating Margin (%) | N/A | -3.557 | -3.2 | 5.532 | 8.009 | -4.057 | 7.117 |
Net Profit Margin (%) | N/A | -1.258 | -22.253 | 4.57 | 0.507 | -5.876 | -3.509 |
Book Value Per Share | N/A | -2.784 | -3.262 | -1.636 | -1.522 | -1.632 | -1.169 |
Earnings Per Share | N/A | -0.049 | -0.811 | 0.101 | 0.012 | -0.143 | -0.069 |
Cash Per Share | N/A | 0.501 | 0.339 | 0.38 | 0.274 | 0.029 | 0.075 |
Working Capital Per Share | N/A | 1.722 | 1.479 | 0.973 | 0.932 | 0.724 | 0.435 |
Operating Profit Per Share | N/A | 2.079 | 1.255 | 0.961 | 1.109 | 1.13 | 0.873 |
EBIT Per Share | N/A | -0.476 | -0.494 | -0.04 | 0.035 | -0.272 | -0.033 |
EBITDA Per Share | N/A | -0.476 | -0.494 | -0.04 | 0.035 | -0.272 | -0.033 |
Free Cash Flow Per Share | N/A | -0.144 | -1.057 | -0.087 | -0.188 | -0.307 | -0.2 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | 115,05M | 147,07M | 147,67M | 149,41M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 7.154 | N/A | N/A | N/A | -1.49 | N/A | N/A |
Net Profit Margin (%) | N/A | -1.245 | N/A | N/A | N/A | -13.902 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,4B |
Ratio cours/bénéfice | -21,65 |
Ratio prix/ventes | 0,75 |
Ratio prix/liquidités | 19,87 |
Ratio prix/valeur comptable | 29,67 |
Rendement de dividende | - |
Actions en circulation | 309,84M |
Volume moyen (1 semaine) | 803,15k |
Volume moyen (1 mois) | 1,07M |
Variation sur 52 semaines | 37,24% |
Plus haut sur 52 semaines | 9,475 |
Plus bas sur 52 semaines | 5,01 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales